User profiles for "author:Robert Verity"

Robert Verity

Research Fellow, Imperial College London
Verified email at imperial.ac.uk
Cited by 20301

[BOOK][B] Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand

NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai… - 2020 - scholar.harvard.edu
The global impact of COVID-19 has been profound, and the public health threat it represents
is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic …

[HTML][HTML] Estimates of the severity of coronavirus disease 2019: a model-based analysis

R Verity, LC Okell, I Dorigatti, P Winskill… - The Lancet infectious …, 2020 - thelancet.com
Background In the face of rapidly changing data, a range of case fatality ratio estimates for
coronavirus disease 2019 (COVID-19) have been produced that differ substantially in …

[HTML][HTML] Reduction in mobility and COVID-19 transmission

P Nouvellet, S Bhatia, A Cori, KEC Ainslie… - Nature …, 2021 - nature.com
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2
transmission by restricting population movement through social distancing interventions …

The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries

PGT Walker, C Whittaker, OJ Watson, M Baguelin… - Science, 2020 - science.org
The ongoing coronavirus disease 2019 (COVID-19) pandemic poses a severe threat to
public health worldwide. We combine data on demography, contact patterns, disease …

[HTML][HTML] Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

AB Hogan, BL Jewell, E Sherrard-Smith… - The Lancet global …, 2020 - thelancet.com
Background COVID-19 has the potential to cause substantial disruptions to health services,
due to cases overburdening the health system or response measures limiting usual …

Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate …

LC Okell, LM Reiter, LS Ebbe, V Baraka, D Bisanzio… - BMJ global …, 2018 - gh.bmj.com
Artemether–lumefantrine (AL) and artesunate–amodiaquine (AS-AQ) are the most
commonly used artemisinin-based combination therapies (ACT) for treatment of …

[HTML][HTML] Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised …

MT White, R Verity, JT Griffin, KP Asante… - The Lancet infectious …, 2015 - thelancet.com
Summary Background The RTS, S/AS01 malaria vaccine targets the circumsporozoite
protein, inducing antibodies associated with the prevention of Plasmodium falciparum …

[HTML][HTML] The potential public health consequences of COVID-19 on malaria in Africa

E Sherrard-Smith, AB Hogan, A Hamlet, OJ Watson… - Nature medicine, 2020 - nature.com
The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and
deaths associated with COVID-19 are rising. In response, countries are implementing …

Estimates of the severity of COVID-19 disease

R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker… - MedRxiv, 2020 - medrxiv.org
Background A range of case fatality ratio (CFR) estimates for COVID-19 have been
produced that differ substantially in magnitude. Methods We used individual-case data from …

Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England

ES Knock, LK Whittles, JA Lees… - Science Translational …, 2021 - science.org
We fitted a model of SARS-CoV-2 transmission in care homes and the community to
regional surveillance data for England. Compared with other approaches, our model …